drugset / Trial / NCT00468845

Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment Of Post-Surgical Pain From Hysterectomy

NCT00468845 ↗

Phase 3 Completed 501 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the efficacy of pregabalin compared to placebo on pain following hysterectomy , measured using subject reported assessments of pain.

Timeline

Start
2007-06
Primary completion
2010-05
Completion
2010-10

Outcome

Missed primary endpoint

registry analysis (unspecified test); Pregabalin 300 mg vs Placebo; p = 0.4710; ANOVA; NCT00468845 ↗

paper There were no statistically significant differences between the pregabalin and placebo groups with respect to the primary endpoint in any of the three trials. PMID 25565885 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 150 mg —
Subject Pregabalin Small molecule 300 mg —

Indications